Glycogen synthase kinase 3β and activin/nodal inhibition in human embryonic stem cells induces a pre-neuroepithelial state that is required for specification to a floor plate cell lineage.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 22911885.
- Also identified by DOI 10.1002/stem.1204 and PMC identifier 3533765.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The floor plate is one of the major organizers of the developing nervous system through its secretion of sonic hedgehog (Shh). Although the floor plate is located within the neural tube, the derivation of the floor plate during development is still debatable and some studies suggest that floor plate cells are specified by Shh in a temporarily restricted window different to neuroepithelial cells. Using human embryonic stem cells (hESC) as a model of neurogenesis, we sought to determine how floor plate cells may be temporarily specified by SHH signaling during human embryogenesis. We found that inhibition of both GSK3β and activin/nodal pathways in hESC induces a cellular state of SOX2+/PAX6- expression, we describe as "pre-neuroepithelial." Exposure of SHH during this pre-neuroepithelial period causes the expression of GLI transcription factors to function as activators and consequently upregulate expression of the floor plate marker, FOXA2, while also supressing PAX6 expression to inhibit neuroepithelial fate. FOXA2+ cells were able to efficiently generate mesencephalic dopaminergic neurons, a floor plate derivative. Overall, this study demonstrates a highly efficient system for generating floor plate cells from hESC and, most importantly, reveals that specification of floor plate cells is temporally dependent, whereby it occurs prior to the onset of PAX6 expression, within a pre-neuroepithelial stage.
Medical subject headings
- Activins
- Activins/antagonists & inhibitors
- Activins/metabolism
- Activins/physiology
- Antigens, Differentiation
- Antigens, Differentiation/metabolism
- Benzamides
- Benzamides/pharmacology
- Body Patterning
- Cell Lineage
- Cells, Cultured
- Cyclohexylamines
- Cyclohexylamines/pharmacology
- Dioxoles
- Dioxoles/pharmacology
- Dopaminergic Neurons
- Dopaminergic Neurons/metabolism
- Embryonic Stem Cells
- Embryonic Stem Cells/enzymology
- Embryonic Stem Cells/physiology
- Eye Proteins
- Eye Proteins/metabolism
- Glycogen Synthase Kinase 3
- Glycogen Synthase Kinase 3/antagonists & inhibitors
- Glycogen Synthase Kinase 3/metabolism
- Glycogen Synthase Kinase 3 beta
- Hedgehog Proteins
- Hedgehog Proteins/physiology
- Hepatocyte Nuclear Factor 3-beta
- Hepatocyte Nuclear Factor 3-beta/metabolism
- Homeodomain Proteins
- Homeodomain Proteins/metabolism
- Humans
- Neural Tube
- Neural Tube/cytology
- Neuroepithelial Cells
- Neuroepithelial Cells/metabolism
- Neuroepithelial Cells/physiology
- Neurogenesis
- Nodal Protein
- Nodal Protein/antagonists & inhibitors
- Nodal Protein/metabolism
- Nodal Protein/physiology
- Nuclear Proteins
- Nuclear Proteins/metabolism
- PAX6 Transcription Factor
- Paired Box Transcription Factors
- Paired Box Transcription Factors/metabolism
- Pyridines
- Pyridines/pharmacology
- Pyrimidines
- Pyrimidines/pharmacology
- Receptors, G-Protein-Coupled
- Receptors, G-Protein-Coupled/agonists
- Receptors, G-Protein-Coupled/metabolism
- Repressor Proteins
- Repressor Proteins/metabolism
- SOXB1 Transcription Factors
- SOXB1 Transcription Factors/metabolism
- Smoothened Receptor
- Thiophenes
- Thiophenes/pharmacology
- Thyroid Nuclear Factor 1
- Transcription Factors
- Transcription Factors/metabolism